Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 4
1995 19
1996 15
1997 20
1998 27
1999 48
2000 55
2001 37
2002 48
2003 48
2004 53
2005 42
2006 38
2007 35
2008 34
2009 29
2010 31
2011 24
2012 20
2013 20
2014 14
2015 19
2016 22
2017 14
2018 16
2019 6
2020 14
2021 9
2022 7
2023 6
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

724 results

Results by year

Filters applied: . Clear all
Page 1
The Interaction Between Allelic Variants of CD86 and CD40LG: A Common Risk Factor of Allergic Asthma and Rheumatoid Arthritis.
Lee SH, Lee EB, Shin ES, Lee JE, Cho SH, Min KU, Park HW. Lee SH, et al. Allergy Asthma Immunol Res. 2014 Mar;6(2):137-41. doi: 10.4168/aair.2014.6.2.137. Epub 2013 Oct 23. Allergy Asthma Immunol Res. 2014. PMID: 24587950 Free PMC article.
RESULTS: MDR analysis revealed a significant gene-gene interaction between -3479T>G CD86 and -3458A>G CD40LG for AA. Subjects with the T/T genotype of -3479T>G CD86 and the A/A genotype of -3458A>G CD40LG were found to be significantly more …
RESULTS: MDR analysis revealed a significant gene-gene interaction between -3479T>G CD86 and -3458A>G CD40LG for AA. Sub …
Immune receptors CD40 and CD86 in oral keratinocytes and implications for oral lichen planus.
Marshall A, Celentano A, Cirillo N, Mirams M, McCullough M, Porter S. Marshall A, et al. J Oral Sci. 2017;59(3):373-382. doi: 10.2334/josnusd.16-0334. J Oral Sci. 2017. PMID: 28904313 Free article.
To further characterize the involvement of CD40 in OLP, expression and distribution of receptor and ligand (CD40/CD154) in tissues from OLP were evaluated by immunohistochemistry. ...The intensity of CD40 staining in OLP tissues was strong. Taken toget …
To further characterize the involvement of CD40 in OLP, expression and distribution of receptor and ligand (CD40/CD154) …
CD80 (B7.1) and CD86 (B7.2) induce EBV-transformed B cell apoptosis through the Fas/FasL pathway.
Park GB, Kim YS, Lee HK, Cho DH, Kim D, Hur DY. Park GB, et al. Int J Oncol. 2013 Nov;43(5):1531-40. doi: 10.3892/ijo.2013.2091. Epub 2013 Sep 5. Int J Oncol. 2013. PMID: 24008628
CD80 and CD86 expression is strongly regulated in B cells and is induced by various stimuli (e.g., cytokines, ligation of MHC class II and CD40 ligand). ...Stimulation of CD80 and CD86 induced expression of Fas ligand (FasL) on EBV-transformed B …
CD80 and CD86 expression is strongly regulated in B cells and is induced by various stimuli (e.g., cytokines, ligation of MHC class I …
Monocyte-derived IL12, CD86 (B7-2) and CD40L expression in relapsing and progressive multiple sclerosis.
Filion LG, Matusevicius D, Graziani-Bowering GM, Kumar A, Freedman MS. Filion LG, et al. Clin Immunol. 2003 Feb;106(2):127-38. doi: 10.1016/s1521-6616(02)00028-1. Clin Immunol. 2003. PMID: 12672403
An increased expression of costimulatory molecules by T cells and antigen-presenting cells is also observed. We hypothesized that in relapsing-remitting MS (RRMS) (with or without of IFNbeta treatment) and in secondary progressive patients (SPMS) IL12 and costimulatory mol …
An increased expression of costimulatory molecules by T cells and antigen-presenting cells is also observed. We hypothesized that in …
CD86 and beta2-adrenergic receptor signaling pathways, respectively, increase Oct-2 and OCA-B Expression and binding to the 3'-IgH enhancer in B cells.
Podojil JR, Kin NW, Sanders VM. Podojil JR, et al. J Biol Chem. 2004 May 28;279(22):23394-404. doi: 10.1074/jbc.M313096200. Epub 2004 Mar 15. J Biol Chem. 2004. PMID: 15024018 Free article.
Stimulation of CD86 (formerly known as B7-2) and/or the beta2-adrenergic receptor on a CD40 ligand/interleukin-4-activated B cell increased the rate of mature IgG1 transcription. ...These effects were lost when CD86-deficient or NF-kappaB …
Stimulation of CD86 (formerly known as B7-2) and/or the beta2-adrenergic receptor on a CD40 ligand/interl …
Co-stimulatory molecules as targets for treatment of lupus.
Merrill JT. Merrill JT. Clin Immunol. 2013 Sep;148(3):369-75. doi: 10.1016/j.clim.2013.04.012. Epub 2013 Apr 29. Clin Immunol. 2013. PMID: 23680362 Review.
Co-stimulatory molecules help to regulate interactions between T cells and antigen-presenting cells and may play an important role in the pathogenesis of lupus. ...To date biologics which provide direct blockade of interactions between CD40 and CD154, B7RP-1 and ICO …
Co-stimulatory molecules help to regulate interactions between T cells and antigen-presenting cells and may play an important role in …
Enhanced expression of CD80 (B7-1), CD86 (B7-2), and CD40 and their ligands CD28 and CD154 in fulminant hepatic failure.
Leifeld L, Trautwein C, Dumoulin FL, Manns MP, Sauerbruch T, Spengler U. Leifeld L, et al. Am J Pathol. 1999 Jun;154(6):1711-20. doi: 10.1016/S0002-9440(10)65427-2. Am J Pathol. 1999. PMID: 10362796 Free PMC article.
To define a possible role for changes in the regulation of antigen presentation in fulminant hepatic failure (FHF), we studied the expression of co-stimulatory molecules CD80 (B7-1), CD86 (B7-2), and CD40 along with their ligands CD28 and CD154. …
To define a possible role for changes in the regulation of antigen presentation in fulminant hepatic failure (FHF), we studied the ex …
CD80 and CD86, but not CD154, augment DNA vaccine-induced protection in experimental bovine tuberculosis.
Maue AC, Waters WR, Palmer MV, Whipple DL, Minion FC, Brown WC, Estes DM. Maue AC, et al. Vaccine. 2004 Dec 21;23(6):769-79. doi: 10.1016/j.vaccine.2004.07.019. Vaccine. 2004. PMID: 15542201
DNA vaccination is known to elicit robust cellular and humoral responses to encoded antigen. The co-administration of costimulatory molecules CD80 (B7-1), CD86 (B7-2) and CD154 (CD40L) has been shown to enhance immune responses in several murine models …
DNA vaccination is known to elicit robust cellular and humoral responses to encoded antigen. The co-administration of costimulatory m …
The role of CD80, CD86, and CTLA4 in alloimmune responses and the induction of long-term allograft survival.
Judge TA, Wu Z, Zheng XG, Sharpe AH, Sayegh MH, Turka LA. Judge TA, et al. J Immunol. 1999 Feb 15;162(4):1947-51. J Immunol. 1999. PMID: 9973463
Previously, we found that CTLA4Ig, which blocks the CD28/CTLA-4 (CD152) ligands CD80 and CD86, can be used to induce transplantation tolerance to vascularized allografts. ...We also report for the first time that blockade of CD86 alone can induce long-term graft sur …
Previously, we found that CTLA4Ig, which blocks the CD28/CTLA-4 (CD152) ligands CD80 and CD86, can be used to induce transplantation …
Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
Chaperot L, Plumas J, Jacob MC, Bost F, Molens JP, Sotto JJ, Bensa JC. Chaperot L, et al. Exp Hematol. 1999 Mar;27(3):479-88. doi: 10.1016/s0301-472x(98)00059-9. Exp Hematol. 1999. PMID: 10089910 Free article.
Among the 70 samples of malignant B cells included, four patterns of expression of the costimulatory molecules CD80 and CD86 were distinguished (+/+, +/-, -/+ and -/-). In two-thirds of the cases, CD80, CD86, or both were expressed. ...We investigated whether malign …
Among the 70 samples of malignant B cells included, four patterns of expression of the costimulatory molecules CD80 and CD86 were dis …
724 results